Involvement of the catecholaminergic system on the antidepressant-like effects of Alpinia zerumbet in mice

References

• Almeida ER. (1993). Plantas Medicinais Brasileiras-Conhecimentos Populares e Científicos. São Paulo: Hemus
   Google Scholar
• Bremner JD, Vythilingam M, Ng CK, et al. (2003). Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 289:3125–34
   PubMed Web of Science ®Google Scholar
• Calixto JB. (2005). Twenty-five years of research on medicinal plants in Latin America: A personal view. J Ethnopharmacol 100:131–4
   PubMed Web of Science ®Google Scholar
• Colla AR, Machado DG, Bettio LE, et al. (2012). Involvement of monoaminergic systems in the antidepressant-like effect of Eugenia brasiliensis Lam. (Myrtaceae) in the tail suspension test in mice. J Ethnopharmacol 143:720–31
   PubMed Web of Science ®Google Scholar
• Cunha MP, Pazini FL, Oliveira Á, et al. (2013). The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 44:39–50
   PubMed Web of Science ®Google Scholar
• de Araújo PF, Coelho-de-Souza AN, Morais SM, et al. (2005). Antinociceptive effects of the essential oil of Alpinia zerumbet on mice. Phytomedicine 12:482–6
   PubMed Web of Science ®Google Scholar
• de Moura RS, Emiliano AF, de Carvalho LC, et al. (2005). Antihypertensive and endothelium-dependent vasodilator effects of Alpinia zerumbet, a medicinal plant. J Cardiovasc Pharmacol 46:288–94
   PubMed Web of Science ®Google Scholar
• Delgado PL, Moreno FA, Onate L, Gelenberg AJ. (2002). Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. Int J Neuropsychopharmacol 5:63–6
   PubMed Web of Science ®Google Scholar
• Gould TD, O’Donnell KC, Dow ER, et al. (2008). Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54:577–87
   PubMed Web of Science ®Google Scholar
• Herrera-Ruiz M, Zamilpa A, González-Cortazar M, et al. (2011). Antidepressant effect and pharmacological evaluation of standardized extract of flavonoids from Byrsonima crassifolia. Phytomedicine 18:1255–61
   PubMed Web of Science ®Google Scholar
• Insel TR, Voon V, Nye JS, et al. (2013). Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev 37:2438–44
   PubMed Web of Science ®Google Scholar
• Kaster MP, Raupp I, Binfaré RW, et al. (2007). Antidepressant-like effect of lamotrigine in the mouse forced swimming test: Evidence for the involvement of the noradrenergic system. Eur J Pharmacol 565:119–24
   PubMed Web of Science ®Google Scholar
• Krishnan V, Nestler EJ. (2010). Linking molecules to mood: New insight into the biology of depression. Am J Psychiatry 167:1305–20
   PubMed Web of Science ®Google Scholar
• Krystal JH, Sanacora G, Duman RS. (2013). Rapid-acting glutamatergic antidepressants: The path to ketamine and beyond. Biol Psychiatry 73:1133–41
   PubMed Web of Science ®Google Scholar
• Kwon S, Lee B, Kim M, et al. (2010). Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 34:265–70
   PubMed Web of Science ®Google Scholar
• Linck VM, Costa-Campos L, Pilz LK, et al. (2012). AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test. Behav Pharmacol 23:171–7
   PubMed Web of Science ®Google Scholar
• Machado DG, Bettio LE, Cunha MP, et al. (2008). Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: Evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 587:163–8
   PubMed Web of Science ®Google Scholar
• Mayorga AJ, Dalvi A, Page ME, et al. (2001). Antidepressant-like behavioral effects in 5-hydroxytryptamine (1A) and 5-hydroxytryptamine (1B) receptor mutant mice. J Pharmacol Exp Ther 298:1101–7
   PubMed Web of Science ®Google Scholar
• Murrough JW, Iosifescu DV, Chang LC, et al. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression: A two-site randomized controlled trial. Am J Psychiatry 170:1134–42
   PubMed Web of Science ®Google Scholar
• Rodrigues AL, da Silva GL, Mateussi AS, et al. (2002). Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70:1347–58
   PubMed Web of Science ®Google Scholar
• Rojas-Corrales MO, Berrocoso E, Micó JA. (2005). Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. Eur J Pharmacol 511:21–6
   PubMed Web of Science ®Google Scholar
• Roman Junior WA, Piato AL, Marafiga Conterato GM, et al. (2013). Psychopharmacological and antioxidant effects of hydroethanolic extract of Alpinia zerumbet leaves in mice. Pharmacog J 5:113–18
   Google Scholar
• Sanacora G, Treccani G, Popoli M. (2012). Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62:63–77
   PubMed Web of Science ®Google Scholar
• Satou T, Murakami S, Matsuura M, et al. (2010). Anxiolytic effect and tissue distribution of inhaled Alpinia zerumbet essential oil in mice. Nat Prod Commun 5:143–6
   PubMed Web of Science ®Google Scholar
• Sobocki P, Jönsson B, Angst J, Rehnberg C. (2006). Cost of depression in Europe. J Ment Health Policy Econ 9:87–8
   PubMed Web of Science ®Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. (1985). The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367–70
   PubMed Web of Science ®Google Scholar
• Victório CP, Arruda R do C de O, Lage CLS, Kuster RM. (2010). Production of flavonoids in organogenic cultures of Alpinia zerumbet. Nat Prod Commun 5:1219–23
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ, et al. (2006). A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856–64
   PubMed Web of Science ®Google Scholar
• Zhou W, Wang N, Yang C, et al. (2013). Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry 29:419–23
   PubMed Web of Science ®Google Scholar